Middle East Healthcare Company (4009) Fair Value & Analysis
Healthcare · SA · Market cap 2.7B SAR
Fair value as of: Jul 31, 2026
From 16 valuation models · updated today
Share price −5.2% over the past month.
What matters now
- The large discount to fair value meets weak quality (38/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (40.98 SAR). The market is more pessimistic than our downside scenario.
Price vs Fair Value (12 months)
12‑month range 28.50 SAR – 58.86 SAR · fair‑value band 40.98 SAR – 69.70 SAR · the 29.74 SAR price screens below the 55.76 SAR fair value. As of Jul 31, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Middle East Healthcare Company (4009) currently trades at 29.74 SAR, while our model-based Fair Value estimate is 55.76 SAR, implying the stock looks roughly 87.5% undervalued today. We read business quality at 38/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Middle East Healthcare Company generated revenue of 3.1B SAR at a net margin of 5.3%. Revenue grew 4.3% year over year. It earns a return on equity of 9.1%. Net debt stands at 2.5B SAR. Fundamentals as of Jul 31, 2026
Our scenario range runs from 40.98 SAR (bear case) to 69.70 SAR (bull case); at 29.74 SAR, the current price sits below that range. The share trades about 50% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -21% fair-value upside, at 87%, 4009 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Middle East Healthcare Company, a healthcare provider, owns and operates a network of hospitals under the Saudi German Hospital name in the Kingdom of Saudi Arabia and internationally. The company operates, manages, and maintains hospitals; and medical, educational, rehabilitation, laboratories and radiology, physiotherapy, and pharmacies centers.
Full company description
Middle East Healthcare Company, a healthcare provider, owns and operates a network of hospitals under the Saudi German Hospital name in the Kingdom of Saudi Arabia and internationally. The company operates, manages, and maintains hospitals; and medical, educational, rehabilitation, laboratories and radiology, physiotherapy, and pharmacies centers. It also buys land to construct medical projects, as well as to establish, manage, construct, and organize exhibitions. The company was founded in 1988 and is based in Jeddah, the Kingdom of Saudi Arabia. Middle East Healthcare Company operates as a subsidiary of Bait Al Batterjee Medical Co. Ltd.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Middle East Healthcare Company reported revenue of 3.1B SAR in FY2025 versus 1.9B SAR in FY2021, a compound +13.5%/yr. Reported net income was 302M SAR in FY2025, compounding +125.2%/yr from FY2021.
Is 4009 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$95.75 | R$123.65 | +29% |
| Fresenius SE FRE | €37.69 | €30.03 | -20% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.50 | R$46.04 | +42% |
| DaVita Inc DVAI34 | R$1,081 | R$207.69 | -81% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,305 | ₹2,546 | -69% |
| Fresenius Medical Care AG FMSC34 | R$120.84 | R$36.43 | -70% |
| Aier Eye Hospital Group 300015 | ¥8.54 | ¥6.73 | -21% |
Compare Middle East Healthcare Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Middle East Healthcare Company (4009) overvalued or undervalued?
What is the fair value of 4009?
What is the quality score of 4009?
What is the revenue of Middle East Healthcare Company (4009)?
What is the net profit margin of 4009?
Does Middle East Healthcare Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Middle East Healthcare Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.